Basel Medical Group Ltd (BMGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | |
| Cash Flows From Operating Activities | ||
| Net Income | -9,832 | 1,774 |
| Depreciation Amortization | 85 | 22 |
| Accounts receivable | -5,727 | -306 |
| Accounts payable and accrued liabilities | 3,410 | 286 |
| Other Working Capital | -2,556 | -4 |
| Other Operating Activity | 11,206 | 79 |
| Operating Cash Flow | $-3,416 | $1,852 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -43 | -6 |
| Net Acquisitions | -8,638 | N/A |
| Investing Cash Flow | $-8,681 | $-6 |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 48 | N/A |
| Debt Issued | 3,145 | N/A |
| Debt Repayment | -6,495 | -1,739 |
| Common Stock Issued | 7,668 | N/A |
| Other Financing Activity | 8,928 | 435 |
| Financing Cash Flow | $13,294 | $-1,304 |
| Exchange Rate Effect | -390 | N/A |
| Beginning Cash Position | 1,534 | 898 |
| End Cash Position | 2,342 | 1,440 |
| Net Cash Flow | $808 | $541 |
| Free Cash Flow | ||
| Operating Cash Flow | -3,416 | 1,852 |
| Capital Expenditure | -43 | -6 |
| Free Cash Flow | -3,459 | 1,846 |